The Real Challenge With AI in Pharma Is Not Finding Another Tool

Pharmaceutical organizations are already operating within complex technology environments. Clinical operations can span clinical trial management systems, electronic data capture, electronic trial master files, safety platforms, laboratory systems, document repositories, analytics environments, and numerous internal and external stakeholders.

Against that backdrop, introducing another AI application does not automatically make operations more efficient. If teams need to move information between systems, upload documents into another platform, review AI-generated outputs, validate the results, and then manually return those results to the original workflow, the organization may have added another layer of work.

This creates an important distinction for pharmaceutical leaders. The question should not simply be "Where can we add AI?" It should be:

"Where can AI remove friction from the workflows our teams already depend on?"

That shift changes how organizations approach pharma AI. Instead of treating AI as another destination, it becomes an intelligence capability that can support existing processes.

What Is Pharma AI?

Pharma AI is the application of artificial intelligence across pharmaceutical activities, including research, drug development, clinical operations, pharmacovigilance, regulatory processes, manufacturing, and commercialization.

Within clinical operations, clinical AI can help teams process information, identify patterns, prioritize activities, retrieve relevant knowledge, and automate appropriate repetitive tasks.

Potential applications include:

• Clinical data analysis
• Trial monitoring
• Site performance analysis
• Document processing
• Operational risk identification
• Protocol-related analysis
• Clinical knowledge retrieval
• Workflow prioritization
• Regulatory document support
• Predictive analytics
• Administrative automation

However, the technology itself is only part of the equation. The value of pharma AI depends on how effectively it fits into the processes people already use.

How Can Clinical AI Improve Clinical Operations?

Clinical AI can improve clinical operations by reducing repetitive information-processing work, helping teams identify important information faster, prioritizing operational risks, and supporting decisions with relevant context.

The purpose is not to automate every clinical decision. It is to reduce the operational workload surrounding those decisions so professionals can focus their attention where expertise and judgment matter most.

1. Reduce Manual Data Review

Clinical teams work with substantial volumes of structured and unstructured information. Reviewing documents, comparing records, identifying inconsistencies, and finding relevant changes can consume significant operational time.

AI can assist with:

• Extracting relevant information
• Summarizing large documents
• Identifying inconsistencies
• Classifying information
• Highlighting exceptions
• Comparing documents
• Prioritizing items for review

The goal is not to remove human review. It is to make human review more targeted.

2. Reduce Information Fragmentation

Clinical operations rarely depend on a single system. Relevant information can be distributed across multiple platforms, databases, documents, and repositories.

This creates a simple but costly problem: people spend time finding information before they can use it.

Clinical AI can potentially help authorized users retrieve and interpret information across existing sources, giving teams greater context without requiring them to manually search every system.

Integration becomes critical here.

An AI capability that requires teams to constantly move information between systems can create more friction. An AI capability embedded into an existing workflow can help reduce it.

3. Prioritize Operational Risks

Clinical operations generate a large amount of information, but not every data point deserves the same level of attention.

AI can help identify patterns that may indicate:

• Delays
• Unusual site performance
• Missing information
• Operational bottlenecks
• Emerging exceptions
• Data-quality concerns
• Activities requiring additional review

The objective should not be another dashboard containing more information.

The more valuable question is:

What requires attention, why does it matter, and who should review it?

That is where clinical AI can move from information generation toward operational support.

4. Accelerate Document-Heavy Processes

Documentation is fundamental to pharmaceutical and clinical operations, but document-heavy processes can also consume considerable staff time.

AI can assist with:

• Document classification
• Information extraction
• Summarization
• Document comparison
• Metadata generation
• Knowledge retrieval
• Draft preparation
• Information validation

This creates an opportunity to reduce repetitive processing while maintaining appropriate human review for decisions and approvals.

Should Pharma Companies Add Another AI Tool?

Not necessarily. In many situations, pharmaceutical organizations may achieve greater value by embedding AI capabilities into existing workflows instead of introducing another standalone application.

Before adopting a new AI platform, leadership should examine the workflow itself.

Ask:

• Where are teams spending excessive time?
• Where is information being manually transferred?
• Which processes involve repetitive document review?
• Where are employees repeatedly searching across systems?
• Which decisions are delayed because relevant information is difficult to access?
• Which activities require expert judgment but contain unnecessary administrative work?
• Can existing systems support the required AI integration?

These questions help distinguish a genuine AI opportunity from a technology-first initiative.

AI Tool vs. AI-Enabled Workflow

There is a significant difference between giving employees an AI tool and using AI to improve an existing workflow.

Consider a clinical operations team that needs to review a large volume of documents to identify potential exceptions.

A disconnected AI application might require the team to:

1. Export information from an existing system.
2. Upload it into the AI application.
3. Generate an analysis.
4. Review the output.
5. Transfer relevant findings back into another system.
6. Continue the original workflow.

The AI may perform its specific task effectively, but the overall process remains fragmented.

A workflow-oriented approach could instead:

1. Access authorized information from existing systems.
2. Process relevant information.
3. Identify potential exceptions.
4. Prioritize findings.
5. Provide supporting context.
6. Route the issue to the appropriate person.
7. Capture the human decision.
8. Maintain an appropriate workflow record.

The difference is fundamental.

The first approach adds AI to the process. The second uses AI to improve the process.

Where Should Pharma Leaders Start With AI?

Pharmaceutical organizations should start with a workflow problem rather than an AI technology.

A practical approach is to work through six stages.

1. Identify the bottleneck

Find processes where teams spend significant time searching, reviewing, reconciling, transferring, or validating information.

2. Define the desired outcome

Determine what improvement would matter to the organization.

Examples include:

• Reducing review time
• Improving turnaround time
• Detecting risks earlier
• Reducing repetitive administrative work
• Improving information accessibility
• Increasing operational visibility

3. Determine whether AI is appropriate

Not every operational problem requires AI.

Some may be better addressed through:

• Process redesign
• System integration
• Rules-based automation
• Data architecture improvements
• Workflow standardization
• Better user interfaces

AI should be used where it provides a meaningful advantage.

4. Establish governance

Clinical AI implementations should consider:

• Data privacy
• Security
• Access controls
• Auditability
• Data quality
• Human oversight
• Regulatory requirements
• Model performance
• Change management

5. Integrate with existing operations

The implementation should minimize unnecessary system switching and manual data movement.

6. Measure the outcome

Success should be measured through operational impact rather than simply counting models, users, or AI features.

Relevant metrics may include:

• Workflow cycle time
• Manual effort
• Review time
• Exception identification
• Data quality
• Decision turnaround
• User adoption
• Operational cost

What Role Should Humans Play in Clinical AI?

Clinical AI should augment human expertise rather than eliminate human accountability.

This is particularly important for workflows involving clinical judgment, regulatory decisions, patient safety, or high-impact operational decisions.

A practical model is:

AI identifies → AI provides context → Human reviews → Human decides → Workflow records

This allows AI to handle appropriate information-processing tasks while qualified professionals retain responsibility for interpretation, judgment, oversight, and decisions.

The objective is not to make clinical teams less important.

It is to reduce the repetitive work that prevents them from focusing on higher-value responsibilities.

What Are the Biggest Challenges With Pharma AI?

The biggest challenges are not limited to AI model performance. Data fragmentation, integration, governance, trust, adoption, and measurable business value can determine whether a pharma AI initiative succeeds.

Data fragmentation

Relevant information may exist across multiple systems with different structures, permissions, and data-quality standards.

Integration

An AI solution that operates independently from existing workflows can create additional manual work.

Governance

Organizations need appropriate controls around data access, security, model usage, monitoring, and accountability.

Adoption

Clinical teams need to understand how AI fits into their responsibilities. Poorly designed workflows can create resistance even when the underlying technology performs well.

Trust

Users need enough context to understand why an AI system has surfaced a particular finding, recommendation, or priority.

ROI

AI initiatives need measurable operational objectives. Technical capability alone does not establish business value.

Leadership Questions to Ask Before Implementing Clinical AI

"What problem are we actually solving?"

If the answer is simply "We need to use AI," the initiative may not yet have a sufficiently defined business case.

Start with the operational problem and determine whether AI is the appropriate solution.

"Will this reduce complexity or add another layer?"

A new AI system should not create unnecessary system switching, duplicated data entry, or additional manual processes.

"Where does human judgment remain necessary?"

Leadership should define which activities AI can support and where human review or approval remains mandatory.

"Can the solution work with our existing systems?"

Integration should be considered during the design phase rather than treated as an implementation detail.

"How will we measure success?"

Define measurable outcomes before deployment.

Possible measures include:

• Time saved
• Workflow efficiency
• Review effort
• Operational risk identification
• Data quality
• Decision turnaround
• User adoption
• Cost reduction

"Can the capability scale beyond one use case?"

A successful AI initiative should ideally create reusable capabilities rather than another isolated implementation.

Can AI Replace Clinical Operations Teams?

No. The more practical role of clinical AI is to augment clinical operations teams by reducing repetitive information-processing work and helping professionals focus on higher-value decisions.

AI can support analysis, prioritization, information retrieval, summarization, and workflow automation. Human professionals remain essential for interpretation, judgment, oversight, accountability, and decisions requiring domain expertise.

The strategic question is therefore not simply whether AI can replace a task.

It is:

How can AI help the team perform the overall workflow more effectively?

What Is the Best Way to Implement AI in Pharma?

Start with a high-value workflow problem, determine whether AI is appropriate, integrate it with existing systems, establish governance and human oversight, and measure the operational outcome.

Starting with an AI model or standalone platform can result in technology-first implementations that fail to address the underlying process.

A workflow-first approach provides a clearer connection between AI investment and measurable business value.

Why Is Integration Important for Clinical AI?

Integration is important because clinical operations depend on interconnected systems, information, and people.

If users must repeatedly move information between systems to use AI, the technology can introduce additional friction.

Integrating AI with appropriate existing workflows can reduce unnecessary system switching, improve information accessibility, and make AI more useful within everyday clinical operations.

What Is the Future of Pharma AI?

The future of pharma AI is likely to move from standalone AI applications toward AI capabilities embedded within the workflows pharmaceutical teams already use.

Instead of asking employees to open another application, AI can increasingly support work within existing operational environments by helping teams:

• Find relevant information
• Process documents
• Identify exceptions
• Prioritize risks
• Analyze patterns
• Automate appropriate administrative activities
• Support human decisions
• Improve operational visibility

The technology becomes less visible while the improvement in the workflow becomes more visible.

The Future of Pharma AI Is Not More Tools

The pharmaceutical industry's AI opportunity is not simply about deploying more models, assistants, dashboards, or applications.

The larger opportunity is to make existing work more efficient without introducing unnecessary complexity.

Clinical teams should not have to think about where the AI lives. When appropriate, AI capabilities should become part of the processes they already perform.

That means the most valuable implementations may not be the ones that look the most technologically impressive. They may be the ones that quietly eliminate repetitive work, surface important information at the right time, and help people make better-informed decisions within the workflow.

For pharmaceutical leaders, this changes the way AI should be evaluated.

The question is no longer simply:

"What can AI do?"

It becomes:

"What can AI improve within the way our organization already works?"

Final Perspective

The goal of pharma AI should not be to add another tool. It should be to create a better workflow.

Clinical operations depend on expertise, coordination, information, systems, and human judgment. AI can contribute significant value when it is designed around those realities rather than placed beside them.

For pharmaceutical organizations evaluating clinical AI, the starting point should therefore be the workflow itself: where teams lose time, where information becomes fragmented, where repetitive processing occurs, and where better intelligence could improve operational decisions.

Once those opportunities are clear, AI becomes a means to an operational outcome rather than the outcome itself.

Discuss your pharma or clinical workflow with Hyena.ai.